Menu
Search
|

Menu

Close
X

ANI Pharmaceuticals Inc ANIP.OQ (NASDAQ Stock Exchange Global Market)

60.36 USD
-0.22 (-0.36%)
As of Feb 22
chart
Previous Close 60.58
Open 60.59
Volume 19,839
3m Avg Volume 23,654
Today’s High 61.07
Today’s Low 60.03
52 Week High 72.81
52 Week Low 39.83
Shares Outstanding (mil) 11.86
Market Capitalization (mil) 715.72
Forward P/E 51.30
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
144
FY17
177
FY16
129
EPS (USD)
FY18
0.845
FY17
1.059
FY16
0.339
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
51.30
35.75
Price to Sales (TTM)
vs sector
3.73
9.77
Price to Book (MRQ)
vs sector
3.72
4.49
Price to Cash Flow (TTM)
vs sector
15.59
26.04
Total Debt to Equity (MRQ)
vs sector
106.91
16.68
LT Debt to Equity (MRQ)
vs sector
103.95
13.13
Return on Investment (TTM)
vs sector
3.81
12.61
Return on Equity (TTM)
vs sector
7.35
13.81

EXECUTIVE LEADERSHIP

Robert Brown
Independent Chairman of the Board, Since 2013
Salary: --
Bonus: --
Arthur Przybyl
President, Chief Executive Officer, Director, Since 2013
Salary: $647,270.00
Bonus: $506,250.00
Stephen Carey
Chief Financial Officer, Vice President - Finance, Since 2016
Salary: $389,233.00
Bonus: $180,000.00
Robert Schrepfer
Senior Vice President -New Business Development and Specialty Sales, Since 2016
Salary: $385,504.00
Bonus: $180,000.00
James Marken
Senior Vice President-Operations and Product Development, Since 2016
Salary: $353,342.00
Bonus: $144,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

210 W Main St
BAUDETTE   MN   56623-2467

Phone: +1218.6343500

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.

SPONSORED STORIES